{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:17:10Z","timestamp":1775063830392,"version":"3.50.1"},"reference-count":117,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2016.00276","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T10:46:30Z","timestamp":1472121990000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Current Status of the New Antiepileptic Drugs in Chronic Pain"],"prefix":"10.3389","volume":"7","author":[{"given":"Harpreet S.","family":"Sidhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Sadhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"issue":"45","key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s12990-015-0048-8","article-title":"KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for trating orofacial cold hyperalgesia.","volume":"11","author":"Abd-Elsayed","year":"2015","journal-title":"Mol. Pain"},{"key":"B2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrn3057","article-title":"Diencephalic and brainstem mechanisms in migraine.","volume":"12","author":"Akerman","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/1073858416628793","article-title":"The anti-allodynic gabapentinoids: myths, paradoxes, and acute effects.","author":"Alles","year":"2016","journal-title":"Neuroscientist"},{"key":"B4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1213\/01.ane.0000247788.57318.1f","article-title":"Levetiracetam reduces anesthetic-induced hyperalgesia in rats.","volume":"104","author":"Archer","year":"2007","journal-title":"Anesth. Analg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1523\/JNEUROSCI.0356-09.2009","article-title":"The increased trafficking of the calcium channel subunit_2_1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin.","volume":"29","author":"Bauer","year":"2009","journal-title":"J. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/BST0380525","article-title":"The anti-allodynic \u03b12\u03b4 ligand pregabalin inhibits the trafficking of the calcium channel \u03b12\u03b4-1 subunit to presynaptic terminals in vivo.","volume":"38","author":"Bauer","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2013.12.012","article-title":"Zonisamide: antihyperalgesic efficacy, the role of serotonergic receptors on efficacy in a rat model for painful diabetic neuropathy.","volume":"95","author":"Bektas","year":"2014","journal-title":"Life Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/0333102410384886","article-title":"Levetiracetam in chronic daily headache: a double-blind randomised placebo-controlled study.","volume":"31","author":"Beran","year":"2011","journal-title":"Cephalalgia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1152\/jn.00168.2014","article-title":"Analysis of the long-term actions of gabapentin and pregabalin in dorsal root ganglia and substantia gelatinosa.","volume":"112","author":"Biggs","year":"2014","journal-title":"J. Neurophysiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.nbd.2010.10.014","article-title":"Migraine preventive drugs differentially affect cortical spreading depression in rat.","volume":"41","author":"Bogdanov","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/01.WNF.0000236766.08409.03","article-title":"Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study.","volume":"29","author":"Brighina","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/brain\/123.8.1703","article-title":"The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine.","volume":"123","author":"Burstein","year":"2000","journal-title":"Brain"},{"key":"B13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ana.21994","article-title":"Thalamic sensitization transforms localized pain into widespread allodynia.","volume":"68","author":"Burstein","year":"2010","journal-title":"Ann. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3892\/or.2015.3718","article-title":"Suppression of KCNQ\/M (Kv7) potassium channels in the spinal cord contributes to the sensitization of dorsal horn WDR neurons and pain hypersensitivity in a rat model of bone cancer pain.","volume":"33","author":"Cai","year":"2015","journal-title":"Oncol. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"8979","DOI":"10.1073\/pnas.1403731111","article-title":"Functional exofacially tagged N-type calcium channels elucidate the interaction with auxiliary \u03b12\u03b4-1 subunits.","volume":"111","author":"Cassidy","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1254\/jphs.CR0050020","article-title":"Mechanisms of the antinociceptive action of gabapentin.","volume":"100","author":"Cheng","year":"2006","journal-title":"J. Pharmacol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1517\/14656566.2014.929665","article-title":"Sodium channel antagonists for the treatment of migraine.","volume":"15","author":"Chiossi","year":"2014","journal-title":"Expert opin. Pharmacotherapy"},{"key":"B18","author":"ClinicalTrials.gov Identifier: NCT00567086","year":"2007","journal-title":"Study to Assess the Safety, Tolerance, and Efficacy of Tezampanel in Patients With Acute Migraine. A Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study to Assess the Safety, Tolerance and Efficacy of a Single Subcutaneous dose of Tezampanel in Patients with Acute Migraine."},{"key":"B19","author":"ClinicalTrials.gov Identifier: NCT00440518","year":"2014","journal-title":"A Study Designed to Test the Effectiveness, and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis. A Prospective, Randomized, Double-Blind, Placebo-Controlled, Monocenterstudy."},{"key":"B20","author":"ClinicalTrials.gov Identifier: NCT01212458","year":"2014","journal-title":"Effect of Oral Rufinamide, and Oxcarbazepine on Nerve Excitability, Hyperalgesia, Allodynia, and Flare Reaction Compared to Placebo. A Monocenter, Randomized, Double-Blind, Cross-Over Study."},{"key":"B21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pain.2007.07.026","article-title":"The roles of sodium channels in nociception: implications for mechanisms of pain.","volume":"131","author":"Cummins","year":"2007","journal-title":"Pain"},{"key":"B22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2+ channel \u03b12\u03b4 ligands: novel modulators of neurotransmission.","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.","volume":"9","author":"Dworkin","year":"2008","journal-title":"J. Pain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/brain\/aws225","article-title":"Neurological prospective on voltage-gated sodium channels.","volume":"135","author":"Eijkelkamp","year":"2012","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1113\/jphysiol.1993.sp019583","article-title":"Characterization of TTX-sensitive and TTX-resistant sodium currents in small cell from adult rat dorsal root ganglia.","volume":"463","author":"Elliott","year":"1993","journal-title":"J. Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ejpain.2005.03.011","article-title":"Specific effect of levetiracetam in experimental human pain models.","volume":"10","author":"Enggaard","year":"2006","journal-title":"Eur. J. Pain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin receptor \u03b12\u03b4-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis.","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","article-title":"EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force.","volume":"16","author":"Evers","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2165\/00019053-199813060-00003","article-title":"The economic burden of migraine to society.","volume":"13","author":"Ferrari","year":"1998","journal-title":"Pharmacoeconomics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.0409066103","article-title":"Identification of the \u03b12\u03b4-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin.","volume":"103","author":"Field","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/sc.2009.55","article-title":"Levetiracetam in spinal cord injury pain: a randomized controlled trial.","volume":"47","author":"Finnerup","year":"2009","journal-title":"Spinal Cord"},{"key":"B32","article-title":"\u201cMigraine and other primary headache disorders,\u201d in","author":"Goadsby","year":"2015","journal-title":"The Harrison\u2019s Principles of Internal Medicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/0333102413499648","article-title":"Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks.","volume":"34","author":"Gomez-Mancilla","year":"2014","journal-title":"Cephalalgia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/AJP.0b013e318197d4cc","article-title":"Anticonvulsants for neuropathic pain: gaps in the evidence.","volume":"25","author":"Goodyear-Smith","year":"2009","journal-title":"Clin. J. Pain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nri3621","article-title":"Pathological pain and the neuroimmune interface.","volume":"14","author":"Grace","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.pmrj.2008.12.004","article-title":"Effectiveness of levetiracetam in the treatment of lumbar radiculopathy: an open-label prospective cohort study.","volume":"1","author":"Hamza","year":"2009","journal-title":"PM R."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1001\/archneur.60.12.1772","article-title":"Levetiracetam for phasic spasticity in multiple sclerosis.","volume":"60","author":"Hawker","year":"2003","journal-title":"Arch. Neurol."},{"issue":"CD009318","key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009318.pub2","article-title":"Lacosamide for neuropathic pain and fibromyalgia in adults.","volume":"2","author":"Hearn","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4161\/chan.2.1.6045","article-title":"Time course and specificity of the pharmacological disruption of the trafficking of voltage-gated calcium channels by gabapentin.","volume":"2","author":"Heblich","year":"2008","journal-title":"Channels (Austin)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4161\/chan.19805","article-title":"Chronic pregabalin inhibits synaptic transmission between rat dorsal root ganglion and dorsal horn neurons in culture.","volume":"6","author":"Hendrich","year":"2012","journal-title":"Channels (Austin)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1586\/17512433.2014.885835","article-title":"Efficacy and mechanism of anticonvulsant drugs in migraine.","volume":"7","author":"Hoffmann","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.ejpain.2010.11.007","article-title":"The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.","volume":"15","author":"Holbech","year":"2011","journal-title":"Eur. J. Pain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature11033","article-title":"\u03b12\u03b4 expression sets presynaptic calcium channel abundance and release probability.","volume":"486","author":"Hoppa","year":"2012","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1468-1331.2012.03857.x","article-title":"Levetiracetam in patients with central neuropathic post-stroke pain \u2013 a randomized, double-blind, placebo-controlled trial.","volume":"20","author":"Jungehulsing","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2174\/1567202612666150603130402","article-title":"Rufinamide improves functional and behavioral deficits via blockade of tetrodotoxin-resistant sodium channels in diabetic neuropathy.","volume":"12","author":"Kharatmal","year":"2015","journal-title":"Curr. Neurovasc. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"8977","DOI":"10.1523\/JNEUROSCI.6494-11.2012","article-title":"Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states.","volume":"32","author":"Kim","year":"2012","journal-title":"J. Neurosci."},{"issue":"55","key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-11-55","article-title":"Fibromyalgia and neuropathic pain-differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia.","volume":"11","author":"Koroschetz","year":"2011","journal-title":"BMC Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12272-013-0057-y","article-title":"Implications and mechanism of action of gabapentin in neuropathic pain.","volume":"36","author":"Kukkar","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.neuint.2013.02.022","article-title":"Systemic pregabalin attenuates facial hypersensitivity and noxious stimulusevoked release of glutamate in medullary dorsal horn in a rodent model of trigeminal neuropathic pain.","volume":"62","author":"Kumar","year":"2013","journal-title":"Neurochem. Int."},{"key":"B50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1468-2982.1999.1901058.x","article-title":"Lamotrigine in the prophylactic treatment of migraine aura\u2013a pilot study.","volume":"19","author":"Lampl","year":"1999","journal-title":"Cephalalgia"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1136\/jnnp.2005.063750","article-title":"Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura.","volume":"76","author":"Lampl","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"CD010608","key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010608","article-title":"Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults.","volume":"6","author":"Linde","year":"2013a","journal-title":"Cochrane Database Syst. Rev."},{"issue":"CD010609","key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010609","article-title":"Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults.","volume":"6","author":"Linde","year":"2013b","journal-title":"Cochrane Database Syst. Rev."},{"issue":"CD010610","key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010610","article-title":"Topiramate for the prophylaxis of episodic migraine in adults.","volume":"6","author":"Linde","year":"2013c","journal-title":"Cochrane Database Syst. Rev."},{"issue":"CD010611","key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010611","article-title":"Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.","volume":"6","author":"Linde","year":"2013d","journal-title":"Cochrane Database Syst. Rev."},{"key":"B56","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy.","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B58","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bbrc.2008.07.145","article-title":"Visualization of SV2A conformations in situ by the use of protein tomography.","volume":"375","author":"Lynch","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2165\/0023210-200923010-00005","article-title":"Eslicarbazepine acetate.","volume":"23","author":"McCormack","year":"2009","journal-title":"CNS Drugs"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: a systematic review.","volume":"311","author":"McQuay","year":"1995","journal-title":"BMJ"},{"key":"B61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1526-4610.1997.3702071.x","article-title":"Loss of productivity and quality of life in migraineurs among French workers: results from the GAZEL cohort.","volume":"37","author":"Michel","year":"1997","journal-title":"Headache"},{"issue":"CD007076","key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults.","volume":"3","author":"Moore","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"CD011241","key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011241.pub2","article-title":"Zonisamide for neuropathic pain in adults.","volume":"1","author":"Moore","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"CD007938","key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub3","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults.","volume":"3","author":"Moore","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"B66","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-5-6","article-title":"Enhanced pre-synaptic glutamate release in deep-dorsal horn contributes to calcium channel alpha-2-delta-1 protein-mediated spinal sensitization and behavioral hypersensitivity.","volume":"5","author":"Nguyen","year":"2009","journal-title":"Mol. Pain"},{"key":"B67","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd3624","article-title":"The neuropathic pain market.","volume":"11","author":"Nightingale","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"B68","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.pain.2013.07.021","article-title":"Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain.","volume":"154 (Supp. 1)","author":"Noseda","year":"2013","journal-title":"Pain"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","article-title":"Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia.","volume":"154","author":"Oaklander","year":"2013","journal-title":"Pain"},{"key":"B70","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1399-6576.2007.01578.x","article-title":"Antinociceptive efficacy of levetiracetam in a mice model for painful diabetic neuropathy.","volume":"52","author":"Ozcan","year":"2008","journal-title":"Acta Anaesthesiol. Scand."},{"key":"B71","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1526-4610.2007.00728.x","article-title":"Levetiracetam prophylaxis in pediatric migraine \u2013 an open-label study.","volume":"47","author":"Pakalnis","year":"2007","journal-title":"Headache"},{"key":"B72","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jnr.23498","article-title":"Painful nerve injury up-regulates thrombospondin-4 expression in dorsal root ganglia.","volume":"93","author":"Pan","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"13335","DOI":"10.1074\/jbc.M116.723478","article-title":"Central Mechanisms Mediating Thrombospondin-4-induced pain states.","volume":"291","author":"Park","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/JPR.S82806","article-title":"Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin.","volume":"8","author":"Parsons","year":"2015","journal-title":"J. Pain Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"16412","DOI":"10.1523\/JNEUROSCI.1026-13.2013","article-title":"\u03b12\u03b4-1 gene deletion affects somatosensory neuron function and delays mechanical hypersensitivity in response to peripheral nerve damage.","volume":"33","author":"Patel","year":"2013","journal-title":"J. Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0304-3959(00)00404-8","article-title":"The effects of GABA (B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat.","volume":"90","author":"Patel","year":"2001","journal-title":"Pain"},{"key":"B77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00002508-200401000-00007","article-title":"Levetiracetam in the treatment of neuropathic pain: three case studies.","volume":"20","author":"Price","year":"2004","journal-title":"Clin. J. Pain"},{"issue":"356","key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia.","volume":"17","author":"Queiroz","year":"2013","journal-title":"Curr. Pain Headache Rep."},{"issue":"45","key":"B79","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-5-45","article-title":"Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain.","volume":"5","author":"Rahman","year":"2009","journal-title":"Mol. Pain"},{"key":"B80","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejphar.2015.12.035","article-title":"Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: influence on spinal microglia and astrocytes.","volume":"771","author":"Reda","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/med\/9780199552764.003.0020","article-title":"\u201cAntiepileptic drugs and migraine,\u201d in","volume":"Vol. 16","author":"Rogawski","year":"2008","journal-title":"The Innovative Drug Development for Headache Disorders"},{"key":"B82","author":"Rogawski","year":"2012","journal-title":"Migraine and Epilepsy, Shared Mechanisms within the Family of Episodic Disorders. Jasper\u2019s Basic Mechanisms of the Epilepsies"},{"key":"B83","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.","volume":"10","author":"Rogawski","year":"2004a","journal-title":"Nat. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs.","volume":"5","author":"Rogawski","year":"2004b","journal-title":"Nat. Rev. Neurosci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1212\/01.WNL.0000079463.16377.07","article-title":"Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia.","volume":"61","author":"Rowbotham","year":"2003","journal-title":"Neurology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1469-7793.1998.771bg.x","article-title":"Electrophysiological properties of sodium current subtypes in small cell from adult rat dorsal root ganglia.","volume":"511","author":"Rush","year":"1998","journal-title":"J. Physiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/0972-2327.144290","article-title":"Comparison of Levetiracetam and sodium Valproate in migraine prophylaxis: a randomized placebo-controlled study.","volume":"18","author":"Sadeghian","year":"2015","journal-title":"Ann. Indian Acad. Neurol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/MJT.0b013e3181d5e4f3","article-title":"Time to onset of neuropathic pain reduction: a retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.","volume":"17","author":"Sharma","year":"2010","journal-title":"Am. J. Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1212\/01.wnl.0000297551.27191.70","article-title":"Oxcarbazepine in migraine headache: a double-blind, randomized, placebocontrolled study.","volume":"70","author":"Silberstein","year":"2008","journal-title":"Neurology"},{"key":"B90","first-page":"953","article-title":"Preemptive levetiracetam decreases postoperative pain in rats.","volume":"29","author":"Sliva","year":"2008","journal-title":"Neuro. Endocrinol. Lett."},{"key":"B91","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1468-1331.2006.01184.x","article-title":"Epidemiology of headache in Europe.","volume":"13(4)","author":"Stovner","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/384560a0","article-title":"Sensitization of meningeal sensory neurons and the origin of headaches.","volume":"384","author":"Strassman","year":"1996","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/ALN.0b013e318278cade","article-title":"Rufinamide attenuates mechanical allodynia in a model of neuropathic pain in the mouse and stabilizes voltage-gated sodium channel inactivated state.","volume":"118","author":"Suter","year":"2013","journal-title":"Anesthesiology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.pain.2005.06.015","article-title":"Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin.","volume":"117","author":"Suzuki","year":"2005","journal-title":"Pain"},{"issue":"5","key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-7-5","article-title":"Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain.","volume":"7","author":"Takeda","year":"2011","journal-title":"Mol. Pain"},{"key":"B96","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/sj.bjp.0706109","article-title":"Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse.","volume":"144","author":"Tanabe","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pain.2008.11.019","article-title":"Mechanisms of analgesia by gabapentin and pregabalin-calcium channel \u03b12-\u03b4 ligands.","volume":"142","author":"Taylor","year":"2009","journal-title":"Pain"},{"key":"B98","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.neuroscience.2008.05.053","article-title":"Immunostaining of rat brain, spinal cord, sensory neurons and skeletal muscle for calcium channel alpha2-delta (alpha2-delta) type 1 protein.","volume":"155","author":"Taylor","year":"2008","journal-title":"Neuroscience"},{"issue":"54","key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00054","article-title":"Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes.","volume":"2","author":"Theile","year":"2011","journal-title":"Front. Pharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1213\/ANE.0000000000000953","article-title":"The efficacy of eslicarbazepine acetate in models of trigeminal, neuropathic, and visceral pain: the involvement of 5-HT1B\/1D serotonergic and CB1\/CB2 cannabinoid receptors.","volume":"121","author":"Tomic","year":"2015","journal-title":"Anesth. Analg."},{"key":"B101","doi-asserted-by":"publisher","first-page":"12856","DOI":"10.1523\/JNEUROSCI.2700-10.2010","article-title":"The alpha2delta ligand gabapentin inhibits the Rab11-dependent recycling of the calcium channel subunit alpha2delta-2.","volume":"30","author":"Tran-Van-Minh","year":"2010","journal-title":"J. Neurosci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1093\/brain\/awt053","article-title":"Small fibre pathology in patients with fibromyalgia syndrome.","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"},{"key":"B103","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WNF.0000000000000005","article-title":"Levetiracetam in migraine prophylaxis: a randomized placebo-controlled study in a rural medical institute in Northern India.","volume":"36","author":"Verma","year":"2013","journal-title":"Clin. Neuropharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2013.10.005","article-title":"Eslicarbazepine acetate: an update on efficacy and safety in epilepsy.","volume":"108","author":"Verrotti","year":"2014","journal-title":"Epilepsy Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1468-1331.2008.02206.x","article-title":"Effect of levetiracetam on the postmastectomy pain syndrome.","volume":"15","author":"Vilholm","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/aps.2015.131","article-title":"KCNQ potassium channels in sensory system and neural circuits.","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"B107","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2165\/11586920-000000000\u201300000","article-title":"Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview.","volume":"13","author":"Wier","year":"2011","journal-title":"Paediatr. Drugs"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001133.pub3","article-title":"Anticonvulsant drugs for acute and chronic pain.","author":"Wiffen","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008314.pub3","article-title":"Topiramate for neuropathic pain and fibromyalgia in adults.","author":"Wiffen","year":"2013a","journal-title":"Cochrane Database of Syst. Rev."},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006044.pub4","article-title":"Lamotrigine for chronic neuropathic pain and fibromyalgia in adults.","author":"Wiffen","year":"2013b","journal-title":"Cochrane Database Syst. Rev."},{"key":"B111","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College Of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee.","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum."},{"key":"B113","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/acr.22207","article-title":"What is fibromyalgia, how is it diagnosed and what does it really mean?","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Care Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1124\/mol.104.010793","article-title":"The new anticonvulsant retigabine favors voltage-dependent opening of Kv 7.2 (KCNQ2) channel by binding to its activation gate.","volume":"67","author":"Wuttke","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/j.1532-2149.2013.00416.x","article-title":"Electrophysiological characterization of spinal neuron sensitization by elevated calcium channel alpha-2-delta-1 subunit protein.","volume":"18","author":"Zhou","year":"2014","journal-title":"Eur. J. Pain"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/ejp.656","article-title":"Nerve injury-induced calcium channel \u03b1-2-\u03b4-1 protein dysregulation leads to increased presynaptic excitatory input into deep dorsal horn neurons and neuropathic allodynia.","volume":"19","author":"Zhou","year":"2015","journal-title":"Eur. J. Pain"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007963.pub2","article-title":"Oxcarbazepine for neuropathic pain.","author":"Zhou","year":"2013","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T12:10:49Z","timestamp":1473250249000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphar.2016.00276\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":117,"URL":"https:\/\/doi.org\/10.3389\/fphar.2016.00276","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]}}}